Forward this message to a friend | Click to view this email in a browser
 
HemoCue-Banner-600x42
   
HemoCue_logo_200x51
Presents a webinar
 
 
 
Optimizing Patient Outcomes with
Point-of-Care hCG Testing
Thursday, July 20, 2017
1:00 - 2:00 PM EDT
PACE® credit will be provided
Both false positives and false negatives for a pregnancy test are clinically significant concerns for the healthcare profession.  In an acute care setting, false negative results can lead to inappropriate procedures and therapies for pregnant women. 

False negative results can increase patient risk and hospital costs by exposing the pregnant patient to procedures that are known to be harmful during pregnancy, especially procedures such as exposure to x-rays and ingestion of contraindicated medications which can harm the fetus.
False negatives can also create delays in obtaining prenatal care. Similarly, false positives can delay necessary treatments. A variety of factors contribute to both false negatives and false positives including low sensitivities, molecular variants, hook effects and other causes.

In this webinar, we will review the current state of hCG testing in POC settings, discuss the limitations and advantages of current methods, and identify recommendations for optimizing pregnancy testing.
REGISTER
   
This webinar will: Continuing education credit:
  • Describe the current state of POC hCG testing
  • Identify potential limitations with POC hCG methods
  • Analyze ways to optimize pregnancy testing to increase patient safety
  • Differentiate important operating characteristics of various POC hCG testing formats
  • 1 PACE® credit-hour will be provided for this Program.
  • This session is approved for 1 Florida Laboratory CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563
REGISTER NOW
Jack-Zakowski Presenter:
Jack J. Zakowski, PhD, FACB
Director, Scientific Affairs and Professional Relations, Beckman Coulter, Inc. 
President, Clinical and Laboratory Standards Institute (CLSI)

Dr. Zakowski's career includes roles in R&D, product development, technical support, clinical affairs, strategic development, and scientific affairs. He is committed to advancing healthcare through the global standardization of clinical diagnostics.
 
Dr. Zakowski has devoted his career to healthcare, entering the clinical chemistry field over 30 years ago. Through his work at Beckman Coulter, and his relationship with some of the industry’s leading professional organizations – AACC, CLSI, ISO, NKDEP, NGSP, and others – he has contributed significantly to improving patient care by helping introduce new technologies and workflow improvements to hospital laboratories across the globe.

Serving on the board of directors of the Clinical and Laboratory Standards Institute (CLSI) - a leader in standards development around the world - he works to promote the development and use of voluntary consensus standards and guidelines within the healthcare community. Dr. Zakowski is currently the President of CLSI. Dr. Zakowski received his doctorate in biochemistry from UC Davis, and completed his training fellowship in clinical chemistry from the University of Virginia Hospital.
   
  ©2017 HemoCue
 
   




Click to view this email in a browser

If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe

Whitehat Communications
2220 Ivy Rd
Charlottesville, Virginia 22903
US